The EMA and HMA Acquired Big Data Strategy to Folster Veterinary Therapies in the EU
Shots:
- Veterinary Big Data strategy has been adopted by EMA & the HMA for 2027 outlining their vision for advancing data-driven, digital innovations in veterinary therapies throughout the EU
- The strategy seeks to integrate traditional regulatory practices with cutting-edge digital solutions, identifying relevant use cases, existing & new data sources, critical infrastructure, and methods to create an environment that fosters innovation for the development of new veterinary therapies providing the benefits to animal & human health and welfare
- The EMA and the entire EU veterinary therapies regulatory network has made significant investments in new IT systems that generate and collect data as part of veterinary legislation's implementation
Ref: European Medicines Agency | Image: EMA
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
